These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 11780304)

  • 1. Miller Fisher syndrome: toward a more comprehensive understanding.
    Li H; Yuan J
    Chin Med J (Engl); 2001 Mar; 114(3):235-9. PubMed ID: 11780304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and immunological spectrum of the Miller Fisher syndrome.
    Lo YL
    Muscle Nerve; 2007 Nov; 36(5):615-27. PubMed ID: 17657801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of Miller Fisher syndrome with anti GQ1b in Thailand.
    Sawanyawisuth K; Tiamkao S; Jitpimolmard S; Vincent A
    J Med Assoc Thai; 2007 Feb; 90(2):391-3. PubMed ID: 17375649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Fisher variant of Guillain-Barré syndrome (Fisher syndrome).
    Snyder LA; Rismondo V; Miller NR
    J Neuroophthalmol; 2009 Dec; 29(4):312-24. PubMed ID: 19952907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual impairment in anti-GQ1b positive Miller Fisher syndrome.
    Colding-Jørgensen E; Vissing J
    Acta Neurol Scand; 2001 Apr; 103(4):259-60. PubMed ID: 11328199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Guillain Barré syndrome in pediatrics].
    Erazo Torricelli R
    Medicina (B Aires); 2009; 69(1 Pt 1):84-91. PubMed ID: 19240005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent miller fisher syndrome with abnormal terminal axon dysfunction: a case report.
    Tomcík J; Dufek M; Hromada J; Rektor I; Bares M
    Acta Neurol Belg; 2007 Dec; 107(4):112-4. PubMed ID: 18416284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits.
    Ang CW; De Klerk MA; Endtz HP; Jacobs BC; Laman JD; van der Meché FG; van Doorn PA
    Infect Immun; 2001 Apr; 69(4):2462-9. PubMed ID: 11254608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-GQ1b-negative Miller Fisher syndrome after Campylobacter jejuni enteritis.
    Lee KY
    Pediatr Neurol; 2012 Sep; 47(3):213-5. PubMed ID: 22883289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Miller Fisher syndrome, Bickerstaff brainstem encephalitis and Guillain-Barré syndrome overlap with persistent non-demyelinating conduction blocks: a case report.
    Puma A; Benoit J; Sacconi S; Uncini A
    BMC Neurol; 2018 Jul; 18(1):101. PubMed ID: 30031375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor and sensory conduction failure in overlap of Guillain-Barré and Miller Fisher syndrome: two simultaneous cases.
    Rajabally YA; Hassan-Smith G; Notturno F; Eames PJ; Hayton T; Capasso M; Uncini A
    J Neurol Sci; 2011 Apr; 303(1-2):35-8. PubMed ID: 21316711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies.
    Kimoto K; Koga M; Odaka M; Hirata K; Takahashi M; Li J; Gilbert M; Yuki N
    Neurology; 2006 Nov; 67(10):1837-43. PubMed ID: 17130419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding.
    Jacobs BC; O'Hanlon GM; Bullens RW; Veitch J; Plomp JJ; Willison HJ
    Brain; 2003 Oct; 126(Pt 10):2220-34. PubMed ID: 12876146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Guillain-Barre syndrome and its frontiers].
    Azulay JP; Verschueren A; Attarian S; Pouget J
    Rev Neurol (Paris); 2002 Dec; 158(12 Pt 2):S21-6. PubMed ID: 12690657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Siglec-7 specifically recognizes Campylobacter jejuni strains associated with oculomotor weakness in Guillain-Barré syndrome and Miller Fisher syndrome.
    Heikema AP; Jacobs BC; Horst-Kreft D; Huizinga R; Kuijf ML; Endtz HP; Samsom JN; van Wamel WJ
    Clin Microbiol Infect; 2013 Feb; 19(2):E106-12. PubMed ID: 23173866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute ophthalmoplegia (without ataxia) associated with anti-GQ1b antibody.
    Lee SH; Lim GH; Kim JS; Oh SY; Kim JK; Cha JK; Yun CH; Kang JK; Lee H; Song HK; Chung KC
    Neurology; 2008 Aug; 71(6):426-9. PubMed ID: 18678825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ganglioside complexes containing GQ1b as targets in Miller Fisher and Guillain-Barre syndromes.
    Kanzaki M; Kaida K; Ueda M; Morita D; Hirakawa M; Motoyoshi K; Kamakura K; Kusunoki S
    J Neurol Neurosurg Psychiatry; 2008 Oct; 79(10):1148-52. PubMed ID: 18339728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-GQ1b IgG-negative case of overlapping Fisher's and Gullain-Barré syndromes after Campylobacter jejuni (PEN 19) enteritis].
    Hayashi Y; Koga M; Takahashi M; Uchida A; Yuki N
    Rinsho Shinkeigaku; 2001 Nov; 41(11):801-4. PubMed ID: 12080613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-GQ1b IgG antibody syndrome: clinical and immunological range.
    Odaka M; Yuki N; Hirata K
    J Neurol Neurosurg Psychiatry; 2001 Jan; 70(1):50-5. PubMed ID: 11118247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.